Vinay Prasad
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Statistics and Probability top 0.5%
- Statistical Methods in Clinical Trials
Papers in
-
- Statistical Methods in Clinical Trials 51
-
- Health Systems, Economic Evaluations, Quality of Life 98
- Economic and Financial Impacts of Cancer 72
- Pharmaceutical Economics and Policy 34
- Co-authors
- Alyson HaslamSham MailankodyPaul B. UmbanhowarDavid A. WeitzJennifer GillEmerson Y. ChenAdam S. CifuAnupam B. Jena
- Journals
- JAMA Internal Medicine (21 papers)JAMA Network Open (20 papers)JAMA Oncology (20 papers)European Journal of Cancer (18 papers)Journal of Cancer Policy (17 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Vinay Prasad
345 papers receiving 8.7k citations
Hit Papers
Peers
Comparison fields: 5 of 191
- Oncology 2.7k
- Statistics and Probability 714
- Economics and Econometrics 2.1k
- Cancer Research 1.2k
- Immunology 926
Countries citing papers authored by Vinay Prasad
This map shows the geographic impact of Vinay Prasad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinay Prasad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinay Prasad more than expected).
Fields of papers citing papers by Vinay Prasad
This network shows the impact of papers produced by Vinay Prasad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinay Prasad. The network helps show where Vinay Prasad may publish in the future.
Co-authors
The 25 scholars most cited alongside Vinay Prasad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 15 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 23 | |
| 10 | 2023 | 17 | |
| 11 | 2022 | 9 | |
| 12 | 2022 | 10 | |
| 13 | 2022 | 3 | |
| 14 | 2022 | 26 | |
| 15 | 2022 | 5 | |
| 16 | 2021 | 10 | |
| 17 | 2020 | 8 | |
| 18 | 2016 | 3 | |
| 19 | Survivability of microencapsulated Lactobacillus acidophilus LA-5 in low fat synbiotic ice cream. | 2014 | 2 |
| 20 | 2014 | 1 |
About Vinay Prasad
Vinay Prasad is a scholar working on Statistics and Probability, Economics and Econometrics, Cancer Research, Oncology and Pharmacology, having authored 372 papers that have together received 8.9k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (98 papers), Economic and Financial Impacts of Cancer (72 papers), Cancer Genomics and Diagnostics (54 papers), Statistical Methods in Clinical Trials (51 papers), Pharmaceutical Economics and Policy (34 papers), Lung Cancer Treatments and Mutations (25 papers), Pharmaceutical industry and healthcare (25 papers) and Cancer Immunotherapy and Biomarkers (18 papers). The work is most often cited by research in Oncology (2.7k citations), Statistics and Probability (714 citations), Economics and Econometrics (2.1k citations), Cancer Research (1.2k citations) and Immunology (926 citations). Vinay Prasad has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Alyson Haslam, Sham Mailankody, Paul B. Umbanhowar, David A. Weitz, Jennifer Gill, Emerson Y. Chen, Adam S. Cifu, Anupam B. Jena, Timothée Olivier and Chul Kim. Their work appears in journals such as JAMA Internal Medicine, JAMA Network Open, JAMA Oncology, European Journal of Cancer and Journal of Cancer Policy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.